Pharmaceutical Marketers Directory


The PMD delivers the marketing insight you need -- all in one place.

Latest News from Medical Marketing & Media

Declining ad rates close two CMPMedica titles

CMPMedica ceased to publish two of its titles - Infections in Medicine and AIDS Reader - due to a continuing decline in print advertising sales.
 

Roche coaches docs, RNs on diabetes care

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetics and their caregivers, and facilitate the integration of Accu-Check products into the lives of patients.
 

Sanofi-Aventis announces R&D restructuring

Sanofi-Aventis announced plans to restructure its R&D model, set to be completed by 2013.
 

Supreme Court shrugs at NH data ban

The Supreme Court will not take on a New Hampshire data ban enacted in 2006, overturned 10 months later by a district court, and then reinstated by a federal appeals court last November.
 

AstraZeneca unbranded effort urges sufferers to "Rethink COPD"

AstraZeneca is rolling out an unbranded COPD education campaign featuring comedian and actor Robert Klein.
 

FDA warns Takeda about Velcade reminder

FDA took issue with a professional mailer and detachable card used at the recent ASCO conference, calling the reminder labeling inappropriate. The ad also overstated the efficacy of Velcade, according to the letter.
 

J&J exec says "public plan" would stymie innovation

Kathleen Buto, vice president, health policy, for Johnson & Johnson told a congressional committee the pharmaceutical industry is concerned a public health plan could undermine a market-based system that provides incentives for long-term research
 

Lawmakers eyeing tax deductions on drug ads

Drug and advertising industry advocates are sounding the alarm over congressional threats to tax drug advertising.
 

Bayer work a blueprint for new consumer health site

DazMedia hopes to leverage its interactive work with Bayer on Betaseron, an MS treatment, into other product and condition areas for a new website: Real World Health. The site is expected to launch during the third quarter, and may include condition areas such as Alzheimer's, diabetes and/or HIV.
 

PhRMA pledges $80 billion in discounts towards health reform cost-cutting

PhRMA has committed to finding $80 billion in savings on drugs sold in the US over ten years, including selling drugs at half-price to seniors in the Medicare Part D "donut hole" coverage gap.
 

Welcome to PMD

The Pharmaceutical Marketers Directory includes just about everything a marketer needs to know about the healthcare industry -- all in one place and all up-to-date. The PMD is a virtual Who's Who in the healthcare field and is filled with valuable information on over 5,000 companies and 15,000 executives. PMD is the healthcare business directory of choice when you need to find pharmaceutical marketing managers, pharmaceutical executives, brand managers and agency executives.

If you're looking to stay connected with the decision-makers in the world of Pharma -- your direct link is here -- the 2009/2010 PMD.

Off the Wire

FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter

U.S. commercial launch planned for the summer of 2009

Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company

Company Will Advance Three Clinical Development Programs in Oncology and Infectious Disease

CombinatoRx and Neuromed Sign Merger Agreement

Merger to Create a Sustainable Biotechnology Company
 Subscribe to the RSS for this page  [view all our RSS feeds here]